|
SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel" or the "Company") (6699.HK) announced its interim results for the first half of 2025. The Company delivered solid performance for the first six months of the year.
In the first half of 2025, Angel reported a year-over-year revenue increase of 33.1% to US$161.4 million, with gross profit of US$100.6 million and adjusted net profit of US$19.5 million. Global clear aligner case volume grew 47.7% year-over-year to approximately 225,800 cases.
The growth in case shipments, along with efficient operations at treatment planning centers and clear aligner manufacturing sites, drove year-over-year improvements in revenue, gross profit, and operating profit. The Company's profitability for the Reporting Period also benefited from stringent expense management in anticipation of an uncertain tariff environment, including the delay in recruitment of certain sales and marketing, clinical support and customer service personnel, as well as delay in operating our treatment planning centers and manufacturing sites outside of Mainland China.
Angel is strategically increasing long-term investments in multiple key areas to build a more sustainable international presence. The Company expects to increase investment in sales and marketing, clinical support and customer service, setting up and operating ex-China treatment planning centers and manufacturing sites, continuously strengthening legal capabilities to advance intellectual property ("IP") strategy and compliance, and further upgrading its data security infrastructure.
In markets outside Mainland China, Angel's case volume increased 103.5% year-over-year to 117,200 cases. The strong growth reflects both the low base in the previous year and initial success in new markets. Angel broadened its reach by providing high-quality treatment planning, reliable deliveries, and continuous educational training programs with key opinion leaders (KOLs).
In Mainland China market, Angel's case volume rose 14% year-over-year to about 108,600 cases. The Company implemented a forward-looking growth strategy, prioritizing early orthodontic treatment and emerging markets as key drivers of sustainable growth.
In the first half of 2025, Angel introduced innovative products and solutions focused on early orthodontic treatment and complex cases, while also incorporating intelligent initial consultations, and treatment monitoring tools into its solutions. The Company conducted research with several universities to produce key clinical innovations.
The company's IP strategy and compliance remain core priorities. As Angel has expanded globally, it has made considerable investments in strengthening its legal capabilities. The company plans to continue its history of product innovation, while vigorously defending its IP rights.
To meet growing market demand, Angel is building a world-class, intelligent manufacturing system that prioritizes user-centricity, environmental sustainability, and scalability. The Company plans to establish or expand manufacturing and treatment planning facilities in key locations worldwide, which will ensure a timely and stable supply of products and services for its customers globally. As an example, treatment planning centers in Brazil and Southeast Asia are currently providing treatment planning services for the United States.
The Company has also devoted substantial resources to upgrading data security infrastructure and operational processes to ensure compliance with data security and privacy regulations in all major markets. This represents a significant investment so far and will remain as an ongoing effort.
Fox Hu, CEO of Angel, stated: "We remain confident in the long-term growth prospects of the global clear aligner industry. Key priorities include scaling production of aligners and treatment plans, enhancing clinical capabilities, continuing our history of product innovation with appropriate IP protection, increasing our investments in compliance while driving sustainable growth across all regions."
About Angelalign Technology Inc.
Founded in 2003 and celebrating 1.5 million smiles, Angelalign Technology Inc. provides digital technology-driven clear aligner products and services to meet the needs of dental professionals and patients worldwide. The Company's innovative products and technical services have established it as a prominent player in the orthodontics industry. In 2021, Angelalign Technology Inc. was listed on the Hong Kong Stock Exchange. In 2023, the Company launched its global expansion strategy, with its products and services now reaching over 50 countries and regions. Learn more at angelaligner.com.
Media Contact:
Sue Kolb
sue.kolb@angelaligner.com
SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel" or the "Company") (6699.HK) announced its interim results for the first half of 2025. The Company delivered solid performance for the first six months of the year.
In the first half of 2025, Angel reported a year-over-year revenue increase of 33.1% to US$161.4 million, with gross profit of US$100.6 million and adjusted net profit of US$19.5 million. Global clear aligner case volume grew 47.7% year-over-year to approximately 225,800 cases.
The growth in case shipments, along with efficient operations at treatment planning centers and clear aligner manufacturing sites, drove year-over-year improvements in revenue, gross profit, and operating profit. The Company's profitability for the Reporting Period also benefited from stringent expense management in anticipation of an uncertain tariff environment, including the delay in recruitment of certain sales and marketing, clinical support and customer service personnel, as well as delay in operating our treatment planning centers and manufacturing sites outside of Mainland China.
Angel is strategically increasing long-term investments in multiple key areas to build a more sustainable international presence. The Company expects to increase investment in sales and marketing, clinical support and customer service, setting up and operating ex-China treatment planning centers and manufacturing sites, continuously strengthening legal capabilities to advance intellectual property ("IP") strategy and compliance, and further upgrading its data security infrastructure.
In markets outside Mainland China, Angel's case volume increased 103.5% year-over-year to 117,200 cases. The strong growth reflects both the low base in the previous year and initial success in new markets. Angel broadened its reach by providing high-quality treatment planning, reliable deliveries, and continuous educational training programs with key opinion leaders (KOLs).
In Mainland China market, Angel's case volume rose 14% year-over-year to about 108,600 cases. The Company implemented a forward-looking growth strategy, prioritizing early orthodontic treatment and emerging markets as key drivers of sustainable growth.
In the first half of 2025, Angel introduced innovative products and solutions focused on early orthodontic treatment and complex cases, while also incorporating intelligent initial consultations, and treatment monitoring tools into its solutions. The Company conducted research with several universities to produce key clinical innovations.
The company's IP strategy and compliance remain core priorities. As Angel has expanded globally, it has made considerable investments in strengthening its legal capabilities. The company plans to continue its history of product innovation, while vigorously defending its IP rights.
To meet growing market demand, Angel is building a world-class, intelligent manufacturing system that prioritizes user-centricity, environmental sustainability, and scalability. The Company plans to establish or expand manufacturing and treatment planning facilities in key locations worldwide, which will ensure a timely and stable supply of products and services for its customers globally. As an example, treatment planning centers in Brazil and Southeast Asia are currently providing treatment planning services for the United States.
The Company has also devoted substantial resources to upgrading data security infrastructure and operational processes to ensure compliance with data security and privacy regulations in all major markets. This represents a significant investment so far and will remain as an ongoing effort.
Fox Hu, CEO of Angel, stated: "We remain confident in the long-term growth prospects of the global clear aligner industry. Key priorities include scaling production of aligners and treatment plans, enhancing clinical capabilities, continuing our history of product innovation with appropriate IP protection, increasing our investments in compliance while driving sustainable growth across all regions."
About Angelalign Technology Inc.
Founded in 2003 and celebrating 1.5 million smiles, Angelalign Technology Inc. provides digital technology-driven clear aligner products and services to meet the needs of dental professionals and patients worldwide. The Company's innovative products and technical services have established it as a prominent player in the orthodontics industry. In 2021, Angelalign Technology Inc. was listed on the Hong Kong Stock Exchange. In 2023, the Company launched its global expansion strategy, with its products and services now reaching over 50 countries and regions. Learn more at angelaligner.com.
Media Contact:
Sue Kolb
sue.kolb@angelaligner.com
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security
HONG KONG, Jan. 16, 2026 /PRNewswire/ -- As we move into 2026, Metis Global (Cook Islands) Limited ("Metis CI"), a subsidiary of Metis Global Group, has officially launched its brand-new regular savings trust plan, the "Starry Pro Plan." The plan integrates regular contributions, international trust protection, and diversified asset allocation arrangements to deliver an integrated solution for clients with medium- to long-term financial planning needs, balancing asset accumulation, structural stability, and legacy planning.
Amid rising market volatility and the increasing prevalence of cross-border allocation, clients are placing greater emphasis on the robustness of legal arrangements when planning for savings, education, or retirement objectives. Metis CI notes that the Starry Pro Plan is designed to help clients establish a forward-looking and disciplined financial structure with an accessible entry threshold.
20-Year Regular Contribution Design to Establish a Stable Financial Rhythm
The Starry Pro Plan adopts a 20-year regular savings trust structure with a standard Contribution Payment Term ("CPT"). Through consistent contributions, clients can gradually accumulate assets and establish a stable rhythm for financial planning under various market conditions. The plan is available for individual or joint applications of up to two persons and primarily targeting medium- to long-term financial goals.
Diverse Underlying Asset Design Supporting Different Financial Orientations
With respect to portfolio selection, the Starry Pro Plan provides two underlying asset options, allowing clients to make choices based on their personal circumstances and overall planning considerations at the point of application.
One option tracks the performance of the S&P 500 Index, representing a widely recognised benchmark of the U.S. equity market across multiple sectors and reflecting the long-term development of mature capital markets. The other is selected by clients from portfolios managed by third-party professional institutions, with allocations and adjustments made according to established investment strategies and market conditions.
Both approaches adopt a regular allocation mechanism to support the gradual accumulation of portfolio value across different market cycles.
International Trust Framework Strengthening Asset Protection and Legacy Arrangements
Metis CI serves as the trustee of the "Starry Pro Plan." Metis CI is a licensed trust company legally registered in the Cook Islands under the Trustee Companies Act 2014 and is regulated by the Cook Islands Financial Supervisory Commission ("FSC"). The Cook Islands is renowned for its mature common law system and the International Trusts Act 1984, and has long been regarded as an international jurisdiction with a robust legal foundation for trusts.
Under the trust structure, clients can appoint beneficiaries through a Letter of Wishes, significantly simplifying the asset transfer process. Assets are held under the independent custody of DBS Bank in Singapore and are fully segregated from the assets of Metis CI, thereby strengthening asset security.
Flexible Mechanisms Designed for Different Life Stages
Recognising that financial circumstances may change during a long-term contribution period, the "Starry Pro Plan" features several flexible options, including a Contribution Holiday, adjustments to contribution amounts, and a partial withdrawal mechanism. Throughout the CPT, clients can utilise up to 24 months of Contribution Holiday in total. Clients may also reduce the regular contribution amount or apply for partial withdrawals after the Initial Contribution Period, ensuring that their planning can adapt flexibly to changing life circumstances.
A Structure-Oriented Financial Tool
Metis CI states that the "Starry Pro Plan" emphasises structural design and medium- to long-term financial thinking. Through a defined contribution framework, a robust trust legal structure, and independent custody arrangements, the plan supports clients in building a more focused and resilient financial blueprint amid ongoing market uncertainty.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Metis "Starry Pro": Achieving Greater Wealth Stability in a Changing Landscape.
